Management of COVID patients with convalescent plasma: Do we have the final word?

Immunotherapy with convalescent plasma (CP) has been used in the past in several different infectious diseases and proposed as a potential therapeutic option in patients with COVID-19. However, a clear benefit was never demonstrated and randomized clinical trials (RCTs) conducted in different popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Menichetti, Francesco, Falcone, Marco, Tiseo, Giusy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. 2022
Materias:
Clinical Insights
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630688/
https://www.ncbi.nlm.nih.gov/pubmed/34895816
http://dx.doi.org/10.1016/j.ejim.2021.10.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630688/
https://www.ncbi.nlm.nih.gov/pubmed/34895816
http://dx.doi.org/10.1016/j.ejim.2021.10.029

Ejemplares similares